rs141905571

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_021615.5(CHST6):​c.465G>A​(p.Arg155Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.008 in 1,612,672 control chromosomes in the GnomAD database, including 119 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0069 ( 10 hom., cov: 33)
Exomes 𝑓: 0.0081 ( 109 hom. )

Consequence

CHST6
NM_021615.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0860

Publications

2 publications found
Variant links:
Genes affected
CHST6 (HGNC:6938): (carbohydrate sulfotransferase 6) The protein encoded by this gene is an enzyme that catalyzes the transfer of a sulfate group to the GlcNAc residues of keratan. Keratan sulfate helps maintain corneal transparency. Defects in this gene are a cause of macular corneal dystrophy (MCD). [provided by RefSeq, Jan 2010]
CHST6 Gene-Disease associations (from GenCC):
  • macular corneal dystrophy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-75479364-C-T is Benign according to our data. Variant chr16-75479364-C-T is described in ClinVar as Benign. ClinVar VariationId is 320612.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.086 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00687 (1046/152348) while in subpopulation SAS AF = 0.0257 (124/4828). AF 95% confidence interval is 0.022. There are 10 homozygotes in GnomAd4. There are 549 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHST6NM_021615.5 linkc.465G>A p.Arg155Arg synonymous_variant Exon 3 of 3 ENST00000332272.9 NP_067628.1
CHST6NR_163480.1 linkn.733+2453G>A intron_variant Intron 3 of 3
CHST6NR_163481.1 linkn.577+2453G>A intron_variant Intron 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHST6ENST00000332272.9 linkc.465G>A p.Arg155Arg synonymous_variant Exon 3 of 3 3 NM_021615.5 ENSP00000328983.4

Frequencies

GnomAD3 genomes
AF:
0.00687
AC:
1046
AN:
152230
Hom.:
10
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.0208
Gnomad AMR
AF:
0.00321
Gnomad ASJ
AF:
0.0280
Gnomad EAS
AF:
0.000962
Gnomad SAS
AF:
0.0257
Gnomad FIN
AF:
0.0175
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00735
Gnomad OTH
AF:
0.00669
GnomAD2 exomes
AF:
0.0106
AC:
2599
AN:
246150
AF XY:
0.0116
show subpopulations
Gnomad AFR exome
AF:
0.000832
Gnomad AMR exome
AF:
0.00256
Gnomad ASJ exome
AF:
0.0263
Gnomad EAS exome
AF:
0.000500
Gnomad FIN exome
AF:
0.0214
Gnomad NFE exome
AF:
0.00838
Gnomad OTH exome
AF:
0.00927
GnomAD4 exome
AF:
0.00812
AC:
11853
AN:
1460324
Hom.:
109
Cov.:
32
AF XY:
0.00876
AC XY:
6361
AN XY:
726542
show subpopulations
African (AFR)
AF:
0.000897
AC:
30
AN:
33462
American (AMR)
AF:
0.00277
AC:
124
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.0257
AC:
671
AN:
26104
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39690
South Asian (SAS)
AF:
0.0252
AC:
2174
AN:
86242
European-Finnish (FIN)
AF:
0.0186
AC:
974
AN:
52238
Middle Eastern (MID)
AF:
0.00832
AC:
48
AN:
5768
European-Non Finnish (NFE)
AF:
0.00654
AC:
7270
AN:
1111758
Other (OTH)
AF:
0.00918
AC:
554
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
915
1830
2745
3660
4575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
272
544
816
1088
1360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00687
AC:
1046
AN:
152348
Hom.:
10
Cov.:
33
AF XY:
0.00737
AC XY:
549
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.00113
AC:
47
AN:
41588
American (AMR)
AF:
0.00320
AC:
49
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.0280
AC:
97
AN:
3470
East Asian (EAS)
AF:
0.000964
AC:
5
AN:
5186
South Asian (SAS)
AF:
0.0257
AC:
124
AN:
4828
European-Finnish (FIN)
AF:
0.0175
AC:
186
AN:
10622
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00735
AC:
500
AN:
68024
Other (OTH)
AF:
0.00662
AC:
14
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
51
102
154
205
256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00976
Hom.:
5
Bravo
AF:
0.00497
Asia WGS
AF:
0.0110
AC:
39
AN:
3478
EpiCase
AF:
0.00643
EpiControl
AF:
0.00699

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Macular corneal dystrophy Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

CHST6-related disorder Benign:1
Mar 14, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
2.1
DANN
Benign
0.83
PhyloP100
-0.086
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141905571; hg19: chr16-75513262; API